Catalyst Capital Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Catalyst Capital Advisors's RGEN Position: Q4 2022 in Review
Catalyst Capital Advisors sold out of Repligen (RGEN) in Q4 2022, closing a stake of 670 shares — an estimated $125K sold.
Catalyst Capital Advisors first reported a position in RGEN in Q2 2018 and held it in 18 quarters. The position peaked at $1.16M in Q3 2018. 441 funds tracked by Wall St. Rank hold RGEN as of Q4 2022.
- Catalyst Capital Advisors reported no remaining Repligen position as of Q4 2022 after selling out during the quarter.
- Catalyst Capital Advisors sold 670 Repligen shares in Q4 2022, an estimated $125K.
- Catalyst Capital Advisors first reported a position in Repligen in Q2 2018 and held it in 18 quarters.
- Catalyst Capital Advisors's Repligen position peaked at $1.16M in Q3 2018.
- 441 funds tracked by Wall St. Rank held Repligen as of Q4 2022.
Based on Catalyst Capital Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.